Myricx Bio brings to Novartis antibody drug conjugates with a novel cancer-killing payload referred to as an NMT inhibitor. Novartis says Myricx’s medicine may have benefits over at the moment obtainable ADCs in addition to these nonetheless in medical improvement.
The publish A $1B Acquisition Provides Novartis a Strategy to Stand Out in Crowded Space of Most cancers appeared first on MedCity Information.
